MedPath

Shanghai Haiyan Pharmaceutical Technology Co., Ltd.

Shanghai Haiyan Pharmaceutical Technology Co., Ltd. logo
🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Safety and Efficacy Study of YZJ-1139 Tablets in Insomnia Disorder

Phase 3
Recruiting
Conditions
Insomnia Disorder
Interventions
First Posted Date
2025-05-16
Last Posted Date
2025-05-16
Lead Sponsor
Shanghai Haiyan Pharmaceutical Technology Co., Ltd.
Target Recruit Count
60
Registration Number
NCT06975514
Locations
🇨🇳

Beijing HuiLongGuan Hospital, Beijing, China

🇨🇳

Peking University People's Hospital, Beijing, China

🇨🇳

ChengDu Second People's Hospital, Chengdu, China

and more 14 locations

A Study of YZJ-4729 Tartrate Injection for the Treatment of Pain After Orthopedic Surgery

Phase 2
Not yet recruiting
Conditions
Pain
Interventions
First Posted Date
2025-03-30
Last Posted Date
2025-03-30
Lead Sponsor
Shanghai Haiyan Pharmaceutical Technology Co., Ltd.
Target Recruit Count
150
Registration Number
NCT06901830
Locations
🇨🇳

The First Hospital of Jilin University, Ch'ang-ch'un, China

🇨🇳

The Third Xiangya Hospital of Central South University, Changsha, China

🇨🇳

Chengdu Second People's Hospital, Chengdu, China

and more 18 locations

A Study of YZJ-4729 Tartrate Injection for the Treatment of Pain After Abdominal Surgery

Phase 3
Not yet recruiting
Conditions
Pain
First Posted Date
2025-03-24
Last Posted Date
2025-03-24
Lead Sponsor
Shanghai Haiyan Pharmaceutical Technology Co., Ltd.
Target Recruit Count
560
Registration Number
NCT06890533
Locations
🇨🇳

The Second People's Hospital of Chengdu, Chengdu, China

🇨🇳

The Third People's Hospital of Chengdu, Chengdu, China

🇨🇳

The First Affiliated Hospital of Chongqing Medical University, Chongqing, China

and more 46 locations

PK/PD Study of YZJ-1139

Phase 1
Completed
Conditions
Insomnia
Interventions
First Posted Date
2024-11-12
Last Posted Date
2024-11-12
Lead Sponsor
Shanghai Haiyan Pharmaceutical Technology Co., Ltd.
Target Recruit Count
20
Registration Number
NCT06685341
Locations
🇨🇳

Beijing Tiantan Hospital, Capital Medical University, Beijing, China

A Phase â…¡ Study to Evaluate the Efficacy and Safety of YZJ-4729 in Patients With Moderate to Severe Acute Pain After Abdominal Surgery

Phase 2
Active, not recruiting
Conditions
Pain
Interventions
First Posted Date
2024-11-08
Last Posted Date
2024-11-08
Lead Sponsor
Shanghai Haiyan Pharmaceutical Technology Co., Ltd.
Target Recruit Count
179
Registration Number
NCT06680466
Locations
🇨🇳

The Third Xiangya Hospital of Central South University, Changsha, Hunan, China

A Clinical Study to Evaluate the Drug Interaction Between YZJ-1139 Tablets and Escitalopram Oxalate Tablets

Phase 1
Active, not recruiting
Conditions
Central Nervous System
Insomnia
Interventions
Drug: YZJ-1139 tablets
Drug: YZJ-1139 simulated tablets
First Posted Date
2024-11-08
Last Posted Date
2024-11-08
Lead Sponsor
Shanghai Haiyan Pharmaceutical Technology Co., Ltd.
Target Recruit Count
24
Registration Number
NCT06680531
Locations
🇨🇳

The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China

Safety and Efficacy Study of YZJ-1139 in Primary Chronic Insomnia Disorder

Phase 2
Completed
Conditions
Insomnia Disorder
Interventions
Drug: YZJ-1139 10mg
Drug: YZJ-1139 20mg
Drug: YZJ-1139 40mg
Drug: YZJ-1139 60mg
Drug: Placebo
First Posted Date
2024-11-08
Last Posted Date
2024-11-08
Lead Sponsor
Shanghai Haiyan Pharmaceutical Technology Co., Ltd.
Target Recruit Count
300
Registration Number
NCT06680505
Locations
🇨🇳

Beijing HuiLongGuan Hospital, Beijing, China

🇨🇳

Peking University People's Hospital, Beijing, China

🇨🇳

Xiangya Hospital, Central South University, Changsha, China

and more 30 locations

A Phase 1 Study of YZJ-4729 Tartrate Injection in Healthy Chinese Subjects

Phase 1
Completed
Conditions
Postoperative Analgesia
Interventions
Drug: YZJ-4729 Tartrate injection
Drug: YZJ-4729 simulated injection
First Posted Date
2024-11-08
Last Posted Date
2024-11-08
Lead Sponsor
Shanghai Haiyan Pharmaceutical Technology Co., Ltd.
Target Recruit Count
66
Registration Number
NCT06681493
Locations
🇨🇳

Xiangya Third Hospital, Central South University, Changsha, China

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of YZJ-1139 in Healthy Participants

Phase 1
Completed
Conditions
Insomnia
Interventions
Drug: Placebo
First Posted Date
2024-11-05
Last Posted Date
2025-02-10
Lead Sponsor
Shanghai Haiyan Pharmaceutical Technology Co., Ltd.
Target Recruit Count
104
Registration Number
NCT06673927
Locations
🇨🇳

Beijing Ditan Hospital Capital Medical University, Beijing, China

A Drug-drug Interaction Study of YZJ-1139 Tablets and Ticagrelor Tablets in Healthy Subjects

Phase 1
Active, not recruiting
Conditions
Insomnia
Interventions
Drug: YZJ-1139 tablets
First Posted Date
2024-11-04
Last Posted Date
2024-11-04
Lead Sponsor
Shanghai Haiyan Pharmaceutical Technology Co., Ltd.
Target Recruit Count
27
Registration Number
NCT06671470
Locations
🇨🇳

Shulan (Hangzhou) Hospital, Huangzhou, China

© Copyright 2025. All Rights Reserved by MedPath